Feasibility of lung cancer hyperthermia using breathable perfluorochemical (PFC) liquids. Part I: Convective hyperthermia

References

• Leopold KA, Oleson JR, Clarke-Pearson D, Soper J, Berchuck A, Samulski T, Page RL, Blivin J, Tomberlin JK, Dewhirst MW. Intraperitoneal cisplatin and regional hyperther-mia for ovarian carcinoma. Int J Radiat Oncol Biol Phys 1993; 27: 1245–51.
   PubMed Web of Science ®Google Scholar
• Overgaard J, Gonzales Gonzales D, Hulshof MCCH, Arcangeli G, Dahl O, Bentzen SM. Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology. Int J Hyperthermia 1996; 12: 3–20.
   PubMed Web of Science ®Google Scholar
• Vernon CC, Hand JW, Field SB, Machin D, Whaley JB, van der Zee J, van Putten WL, van Rhoon GC, van Dijk JD, Gonzalez Gonzalez D, Liu FF, Goodman P, Sherar M. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials, International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys 1996; 35: 731–44.
   Google Scholar
• Sneed PK, Stauffer PR, McDermott MW, Diederich CJ, Lamborn KR, Prados MD, Chang S, Weaver KA, Spry L, Malec MK, Lamb SA, Voss B, Davis RL, Wara WM, Larson DA, Phillips TL, Gutin PH. Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1998; 40: 287–95.
   Google Scholar
• van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000; 355: 1119–25.
   PubMed Web of Science ®Google Scholar
• Sekins KM, Keilman GW, Anderson TA, Shaffer TH. Lung cancer hyperthermia via ultrasound and PFC liquids. Abstracts of 5th International Symposium on Hyperthermic Oncology; Kyoto, Japan, 1988 August 29–3 September; 1988: 159.
   Google Scholar
• Bleehan NM. Role of hyperthermia in treatment of lung cancer. In: Bleehan N, ed. Cancer Treatment Symposia, Vol. 2, Basel: Karger Landes, 1985: 75.
   Google Scholar
• Bull JMC. A review of systemic hyperthermia. Front Radiat Ther Oncol 1984; 18: 171–6.
   PubMedGoogle Scholar
• Robins HI, Hugander A, Cohen JD. Whole body hyperthermia in the treatment of neoplastic disease. Radiol Clin North Am 1989; 27: 603–10.
   PubMed Web of Science ®Google Scholar
• Burd R, Dziedzic TS, Xu Y, Caligiuri MA, Subjeck JR, Repasky EA. Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever-like) whole body hyperthermia. J Cell Physiol 1998; 177: 137–47.
   PubMed Web of Science ®Google Scholar
• Wust P, Riess H, Hildebrandt B, Loffel J, Deja M, Ahlers O, Kerner T, von Ardenne A, Felix R. Feasibility and analysis of thermal parameters for whole body hyperthermia system IRATHERM-2000. Int J Hyperthermia 2000; 16: 325–39.
   Google Scholar
• Kakehi M, Ueda K, Mukojima T, Hiraoka M, Seto O, Akanuma A, Nakatsugawa S. Multi-institutional clinical studies on hyperthermia combined with radiotherapy or chemotherapy in advanced cancer of deep-seated organs. Int J Hyperthermia 1990; 6: 719–40.
   Google Scholar
• Johnston MR, Minchen RF, Dawson CA. Lung perfusion with chemotherapy in patients with unresectable metastatic sarcoma to the lung or diffuse bronchioloalveolar carcinoma. J Thorac Cardiovasc Surg 1995; 110: 368–73.
   Google Scholar
• Rickaby DA, Fehring JF, Johnston MR, Dawson CA. Tolerance of the isolated perfused lung to hyperthermia, J Thorac Cardiovasc Surg 1991; 101: 732–9.
   PubMedGoogle Scholar
• Meyer RE, Berry CR, Lee .1.1, Dodge RK, Page RL, Thrall DE. Inspired anaesthetic gas humidification improves thermal uniformity during canine whole body hyperthermia. Int J Hyperthennia 1995; 11: 397–407.
   Google Scholar
• Sekins KM, Shaffer TH, Wolfson MW, Hoffman JK, Keilman G, Ziskin MC, Leeper DB. Feasibility of lung cancer hyperthermia using breathable perfluorochemical (PFC) liquids. Part II: Ultrasound Hyperthermia. Int J Hyperthermia (this issue).
   Google Scholar
• Clark LC, Gollan F. Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure. Science 1966; 152: 1755–6.
   PubMed Web of Science ®Google Scholar
• Shaffer TH. A brief review: liquid ventilation. Undersea Biomedical Research 1987; 14: 169–79.
   PubMedGoogle Scholar
• Fuhrman BP, Hernan Li, Rotta AT. Partial Liquid Ventilation: A multifaceted approach to acute respiratory distress syndrome. New Horizons (Special Issue on Pediatric Respiratory Failure, eds Goldstein W, Arnold J) 1999; 7: 433–9.
   Google Scholar
• Tutuncu AS, Faithful! NS, Lachmann B. Comparison of ventilatory support with intratracheal perfluorocarbon administration and conventional mechanical ventilation in animals with acute respiratory failure. Am Rev Respir Dis 1993; 148: 785–92.
   PubMed Web of Science ®Google Scholar
• Leach CL, Greenspan JS, Rubenstein SD, Shaffer TH, Wolfson MR, Jackson JC, deLemos R, Fuhrman BP. Partial liquid ventilation with perflubron in premature infants with severe respiratory distress syndrome (RDS). The LiquiVent Study Group, N Engl J Med 1996; 335: 761–7.
   PubMed Web of Science ®Google Scholar
• Hirschl RB, Bartlett R, Gauger P, Overbeck M, Pranikoff T, Schreiner R, Wise C. Initial experience with partial liquid ventilation in adult patients with Acute Respiratory Distress Syndrome. J Am Med Assoc 1996; 275: 383–9.
   Google Scholar
• Toro-Figueroa L, Curtis S, Fackler J, Fuhrman B, Hirschl R, Leach C, Meliones J, Newth C, Thompson A. Perflubron partial liquid ventilation (PLV) in children with ARDS: a safety and efficacy pilot study. Crit Care Med 1996; 24: A150.
   Google Scholar
• Bartlett R, Croce M, Hirschl R, Gore D, Weidemann H, Zwischenberger J. A Phase II randomized, controlled trial of partial liquid ventilation (PLV) in adult patients with acute hypoxemic respiratory failure (AHRF). Crit Care Med 1997; 25 (suppl.): A35.
   Google Scholar
• Teicher BA, An overview of oxygen carriers in cancer therapy. Artif Cells Blood Substit, Immobil Biotechnol 1995; 23: 395–405.
   PubMed Web of Science ®Google Scholar
• Lustig R, Lowe N, Prosnitz L. Fluosol and oxygen breathing as an adjuvant to radiation therapy in the treatment of locally advanced nonsmall cell carcinoma of the lung: results of Phase I/II study. Int J Radiat Oncol Biol Phys 1990; 19: 97–102.
   Google Scholar
• Spahn DR, van Brempt R, Theilmeier G, Reibold JP, Welte M, Heinzerling H, et al. Perflubron emulsion delays blood transfusions in orthopedic surgery. Anesthesiology 1999; 91: 1195–1208.
   PubMed Web of Science ®Google Scholar
• Spahn, DR. Phase 3 general surgery efficacy results of OxygentTM in reduction and avoidance of blood transfusions. In: Proceedings of the European Society of Anesthesiology Conference, 9 April 2001, Grottenberg, Sweden.
   Google Scholar
• Hirschl RB, Tooley R, Parent AC, Tooley R, Johnson K, Bartlett RH. Improvement of gas exchange, pulmonary function, and lung injury with partial liquid ventilation: a study model in the setting of severe respiratory failure. Chest 1995; 108: 500–8.
   PubMed Web of Science ®Google Scholar
• Kirmse M, Fujino Y, Hess D, Kacmarek RM. Positive end-expiratory pressure improves gas exchange and pulmonary mechanics during partial liquid ventilation. Am J Respir Crit Care Med 1998; 158: 1550–6.
   PubMedGoogle Scholar
• Wolfson MR, Greenspan JS, Deoras KS, Rubenstein SD, Shaffer TH. Comparison of gas and liquid ventilation: clinical, physiological, and histological correlates, J Appl Physiol 1992; 72: 1024–31.
   Google Scholar
• Hirschl RB, Parent A, Tooley R, McCracken M, Johnson K, Shaffer TH et al. Liquid ventilation improves pulmonary function, gas exchange, and lung injury in a model of respiratory failure. Ann Surg 1995; 221: 79–88.
   PubMed Web of Science ®Google Scholar
• Wolfson MR, Jackson JC, Foley DS, Hirschl RB, Gauvin F, Lamm WJ, et al. Multi-center comparative study of conventional mechanical (CMV) to tidal liquid ventilation (TLV) in oleic acid (OA) injured sheep. Am J Respir Crit Care Med 2000; 161: A46.
   Google Scholar
• Riess JG, Keipert PE. Update on perfluorocarbon-based oxygen delivery systems. In: Tuchida E, ed. Blood Substitutes Present and Future Perspectives. Amsterdam:Elsevier Science, 1998: 91–102.
   Google Scholar
• Gauger P, Hirschl R, Moler F, Pranikoff T, Schreiner R. Initial experience with partial liquid ventilation in pediatric patients with the acute respiratory distress syndrome. Crit Care Med 1996; 24: 16–22.
   Google Scholar
• Lowe CA, Shaffer TH. Pulmonary vascular resistance in the fluorocarbon filled lung. J Appl Physiol 1986; 60: 154–9.
   PubMed Web of Science ®Google Scholar
• Doctor A, Ibla JC, Grenier BM, Zurakowski D, Ferretti ML, Thompson JE, Lillehei CW, Arnold JR. Pulmonary blood flow distribution during partial liquid ventilation. J Appl Physiol 1998; 84:1540–50.
   PubMedGoogle Scholar
• Sajan I., Scannapieco FA, Fuhrman BP, Steinhorn DM. The risk of nosocomial pneumonia is not increased during partial liquid ventilation. Crit Care Med 1999; 27: 2741–47.
   Google Scholar
• Varani J, Hirsch! R, Dame M, Johnson K. Perfluorocarbon protects lung epithelial cells from neutrophil-mediated injury in an in vitro model of liquid ventilation therapy. Shock 1996; 6: 339-4.4.
   Google Scholar
• Smith D, Sun X, Neslund G, Flaim SF. Effects of perflubron (LiquiVent) on human leukocyte activation in vitro. Am J Respir Crit Care Med 1997; 155: A752.
   Google Scholar
• Woods, CM, Neslund G, Kornbrust ES, Flaim, SF. Perflubron attenuates neutrophil adhesion to activated endothelial cells in vitro. Am J Physiol Lung Cell Mol Physiol 2000; 278: L1008–17.
   Google Scholar
• Miller TF, Milestone B, Stern R, Shaffer TH, Wolfson MR. Effect of perfluorochemical (PFC) properties on PFC distribution, elimination, and lung mechanics during partial liquid ventilation. Am J Respir Crit Care Med 1998; 157: A462.
   Google Scholar
• Quintel M, Hirschl RB, Roth H, Loose R, Tillmanns R, van Ackern K, Bartlett RH. Assessment of perfluorocarbon (PFC) distribution during partial liquid ventilation (PLV) in the setting of acute respiratory failure. Am J Respir Crit Care Med 1995; 151: A446.
   Google Scholar
• Mattrey RF, Perfluorooctylbromide: a new contrast agent for CT, sonography and MR imaging. Am J Radiol 1989; 152: 247–52.
   Google Scholar
• Sekins KM, Nugent L, Mazzoni M, Flanagan C, Neer L, Rozenberg A, Hoffman J. Recent innovations in total liquid ventilation system and component design. Biorned Instrurn Technol 1999; 33: 277–84.
   Google Scholar
• Forman DL, Bhutani VK, Tran N, Shaffer TH. A new approach to induced hypothermia. J Surg Res 1986; 40: 36–42.
   PubMedGoogle Scholar
• Wolfson MR, Greenspan JS, Shaffer TH. Liquid-assisted ventilation: an alternative respiratory modality. Pediatr Pulrnonol 1998; 26: 42–63.
   Google Scholar
• Riess JG. Fluorocarbon-based oxygen-delivery: basic principles and product develop-ment. In: TMS Chang, ed. Blood Substitutes: Principles, Methods, Products and Clinical Trials. Basel: Karger Landes, 1998: 101–26.
   Google Scholar
• Weers JG. A Physicochemical evaluation of perfluorochemicals for oxygen transport applications, J Fluorine Chem 1993; 64: 73–93.
   Google Scholar
• Wolfson MR, Tran N, Butani VK, Shaffer TH. A new experimental approach for the study of cardiopulmonary physiology during early development. J Appl Physiol 1988; 65: 1436–43.
   PubMed Web of Science ®Google Scholar
• Sapareto SA. Thermal isoeffect dose: addressing the issue of thermotolerance. Int J Hypertherrnia 1987; 3: 297–305.
   PubMed Web of Science ®Google Scholar
• Dewey WC. Arrhenius relationships from the molecule and cell to the clinic. Int J Hypertherrnia 1994; 10:457–83.
   PubMed Web of Science ®Google Scholar
• Honda N, Oda S, Noguchi T, Hayano Y. Reversibility of effects of systemic hyperthermia at 43°C. In: Sugahara T, Saito M., eds. Hypertherrnic oncology 1988, Vol. 1. London: Taylor & Francis, 1989: 310–11.
   Google Scholar
• Bull, JMC, Cronau LH, Mansfield A, Newman B, Jabboury K, Allen SJ, Ohno S, Smith T, Tonnesen AS. Chemotherapy resistant sarcoma treated with whole body hyperthermia (WBH) combined with 1-3-bis (2-chloroethyl)-1-nitrosourea (BCNU). Int J Hypertherrnia 1992; 8:297–304.
   PubMed Web of Science ®Google Scholar
• McChesney GS, Dawson CA, Scott RJ, Rickaby DA, Powers BE, Johnston MR, Chen C, Gillette EL. Whole body hyperthermia combined with hyperfractionated irra-diation of the thorax in dog: acute physiological response. Int j Hypertherrnia 1993; 9:369–82.
   PubMedGoogle Scholar
• Robins HI, Woods JP, Schmitt CL, Cohen JD. A new technological approach to radiant heat whole body hyperthermia. Cancer Lett 1994; 79:137–45.
   PubMed Web of Science ®Google Scholar
• Hosotani K, Katsumura H, Kabuto M, Handa Y, Kubota T, Hayashji M. Effect of whole-body hyperthermia on the development of peritumoral brain oedema. Int J Hypertherrnia 1993; 9:25–36.
   PubMed Web of Science ®Google Scholar
• Henle KJ. Sensitization to hyperthermia below 43 degrees C induced in Chinese hamster ovary cells by step-down heating. J Natl Cancer Inst 1980; 64:1479–83.
   PubMedGoogle Scholar
• Mandl M, Harris K, Wolfson MR, Shaffer TH. Perflubron (PFB) content in blood and tissue during partial liquid ventilation (PLV) correlates with core body temperature. Eur J Med Res 2000; 5: A10.
   Google Scholar
• Shaffer TH, Foust R, Wolfson MR, Miller TF. Analysis of perfluorochemical elimination from the respiratory system. J Appl Physiol 1997; 83:1033–40.
   PubMed Web of Science ®Google Scholar
• Modell JH, Calderwood HW, Ruiz BC, Tham MK, Hood CI. Liquid ventilation of primates. Chest 1976; 69:79–81.
   Google Scholar
• Wolfson MR, Greenspan JS, Shaffer TH. Pulmonary administration of vasoactive substances by perfluorochemical ventilation. Pediatrics 1996; 97:449–55.
   Google Scholar
• Mrozek JD, Smith KM, Bing DR, Meyers PA, Simonton SC, Connett JE, Mammel MC. Exogenous surfactant and partial liquid ventilation; physiologic and pathologic effects. Am J Respir Crit Care Med 1997; 156:1058–65.
   Google Scholar
• Dickson EW, Heard SO, Chu B, Fraire A, Brueggemann AB, Dorn GV. Partial liquid ventilation with perfluorocarbon in the treatment of rats with lethal pneumococcal pneumonia. Anesthesiology 1998; 88:218–23.
   PubMed Web of Science ®Google Scholar
• Weiss DJ, Strandjord TP, Liggitt D, Clark JG. Perflubron enhances adenovirus-mediated gene expression in lungs of transgenic mice with chronic alveolar filling. Hum Gene Ther 1999; 10:2287–93.
   PubMed Web of Science ®Google Scholar
• Houmes RJM, Hartog A, Verbrugge SJC, Bohm S, Lachmann B. Combining partial liquid ventilation with nitric oxide to improve gas exchange in acute lung injury. Int Care Med 1997; 23:163–9.
   Google Scholar
• Kimless-Garber DB, Wolfson MR, Carlsson S, Shaffer TH. Halothane administration during liquid ventilation. Respir Med 1997; 91:255–62.
   Google Scholar
• Shellhammer DF. Perflubron as a drug delivery system for pulmonary disorders. Internal Report. San Diego: Alliance Pharmaceutical Corp., 1994.
   Google Scholar
• Krafft MP, Riess J. Compositions highly concentrated in fluorocarbons for drug delivery. Internal Report. San Diego: Alliance Pharmaceutical Corp., 1993.
   Google Scholar